# The National Myelodysplastic Syndromes (MDS) Study

> **NCT02775383** · — · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 2115 (actual)

## Conditions studied

- Myelodysplastic Syndromes (MDS)

## Interventions

- **OTHER:** Therapeutic

## Key facts

- **NCT ID:** NCT02775383
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-13
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 2115 (ACTUAL)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02775383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02775383, "The National Myelodysplastic Syndromes (MDS) Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02775383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*